Novavax Inc (XSWX:NVAX)
CHF 7.61 -0.14 (-1.78%) Market Cap: 1.24 Bil Enterprise Value: 843.42 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 50/100

Novavax Inc Annual Shareholders Meeting Transcript

Jun 18, 2026 / 12:30PM GMT
Release Date Price: CHF7.51 (+1.35%)
Operator

Good day, and thank you for standing by. I would now like to turn the call over to John Jacobs, CEO of Novavax. Please go ahead.

John Jacobs;Mark Casey
Novavax Inc - President, Chief Executive Officer, Director;Novavax Inc - Executive Vice President,

Good morning, and thank you, everyone, for joining us today. I'm pleased to be together with all of you for our 2026 Annual Meeting of Stockholders. Before we begin, I'd like to thank the members of our Board of Directors, including our Chairman, Dave Mott, who are in attendance this morning. I'm pleased to introduce additional representatives from our executive leadership team that are here with us today, including Jim Kelly, our Chief Financial Officer and Treasurer; and Mark Casey, our Chief Legal Officer and Corporate Secretary, who will conduct a business portion of today's meeting. Following the business portion of the meeting, I will make some brief closing remarks.

The meeting will now officially come to order. And with that, I'd like to hand it over to Mark Casey.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot